Correlation Between Adial Pharmaceuticals and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Adial Pharmaceuticals and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adial Pharmaceuticals and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adial Pharmaceuticals and Emergent Biosolutions, you can compare the effects of market volatilities on Adial Pharmaceuticals and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adial Pharmaceuticals with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adial Pharmaceuticals and Emergent Biosolutions.
Diversification Opportunities for Adial Pharmaceuticals and Emergent Biosolutions
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Adial and Emergent is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Adial Pharmaceuticals and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Adial Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adial Pharmaceuticals are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Adial Pharmaceuticals i.e., Adial Pharmaceuticals and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Adial Pharmaceuticals and Emergent Biosolutions
Given the investment horizon of 90 days Adial Pharmaceuticals is expected to under-perform the Emergent Biosolutions. In addition to that, Adial Pharmaceuticals is 1.16 times more volatile than Emergent Biosolutions. It trades about -0.12 of its total potential returns per unit of risk. Emergent Biosolutions is currently generating about -0.1 per unit of volatility. If you would invest 929.00 in Emergent Biosolutions on December 3, 2024 and sell it today you would lose (246.00) from holding Emergent Biosolutions or give up 26.48% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Adial Pharmaceuticals vs. Emergent Biosolutions
Performance |
Timeline |
Adial Pharmaceuticals |
Emergent Biosolutions |
Adial Pharmaceuticals and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Adial Pharmaceuticals and Emergent Biosolutions
The main advantage of trading using opposite Adial Pharmaceuticals and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adial Pharmaceuticals position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.Adial Pharmaceuticals vs. Transcode Therapeutics | Adial Pharmaceuticals vs. Aditxt Inc | Adial Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Adial Pharmaceuticals vs. Avenue Therapeutics |
Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Akanda Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |